Latest in News & Research

Sleep Disturbance Highly Prevalent in Psoriasis Patients

Strongest predictors of sleep impairment include anxiety and depression levels, pruritus exacerbation at night, in morning

By Physician’s Briefing Staff | | February 15, 2022

Acral Lentiginous Melanoma Survival Varies by Race, SES

Differences in socioeconomic status contribute to survival disparities for Hispanic Black and White patients

By Physician’s Briefing Staff | | February 14, 2022

Persons With Homelessness Have Higher Odds of Group A Streptococcus SSTIs

However, first-line antibiotic coverage against MRSA more often given to persons experiencing homelessness

By Dermsquared Editorial Team | | February 09, 2022

Clinical Experts Develop Severity Scale for Alopecia Areata

Scale uses extent of scalp hair loss as primary basis for severity rating and includes four secondary features

By Dermsquared Editorial Team | | February 09, 2022

Twenty-Nine Novel Loci Identified for Acne Susceptibility

Meta-analysis of genome-wide association studies adds to knowledge of genetic contribution to acne susceptibility

By Physician’s Briefing Staff | | February 09, 2022

Knowledge of High Skin Cancer Risk Might Modify Risky Behaviors

Those at high risk of skin cancer accurately assessed risk and reported lower likelihood of future tanning bed use

By Physician's Briefing Staff | | February 08, 2022

Nivolumab Combo Treats Advanced Esophageal Squamous-Cell Carcinoma

Overall survival longer in patients receiving first-line treatment with nivolumab plus chemo or nivolumab plus ipilimumab versus chemo alone

By Physician’s Briefing Staff | | February 03, 2022

Which Treatment Is Most Efficacious for Male Androgenetic Alopecia?

Greatest increase in first end point of total hair count at 24 weeks was seen for 0.5 mg/day dutasteride

By Dermsquared Editorial Team | | February 02, 2022

How Does MMS Compare to Wide Local Excision for cSCC?

Mohs micrographic surgery is less expensive and results in 2.22 weeks of perfect health gained over five years versus WLE

By Dermsquared Editorial Team | | February 02, 2022

Metastases Occur in About 2 Percent of Cutaneous SCCs

Risk factors for metastases include age, male sex, and immunosuppression

By Physician's Briefing Staff | | February 01, 2022

Pfizer Will Ask FDA to Approve Its COVID-19 Vaccine for Children Under 5 Years

If approved, the two-shot regimen would become the first approved for use in children this young

By Physician’s Briefing Staff | | February 01, 2022

Novel Algorithm May Help Classify Skin Diseases

New algorithm uses multistage fusion process that includes clinical images, dermoscopy images, and patient meta-data

By Physician’s Briefing Staff | | January 31, 2022

Reporting of Race, Ethnicity Has Improved in Dermatology Trials

However, proportion of reporting articles including at least 20 percent non-White representation unchanged at 38.1 percent

By Dermsquared Editorial Team | | January 26, 2022

How Does Risankizumab Compare to Fumaric Acid Esters for Plaque Psoriasis?

Significantly more patients achieved ≥90 percent improvement in PASI at week 24 with risankizumab versus FAE

By Dermsquared Editorial Team | | January 26, 2022

Skyrizi Approved for Psoriatic Arthritis

Approval based on two Phase 3 trials showing more than 50 percent of patients receiving Skyrizi achieved ACR20 response at 24 weeks

By Physician’s Briefing Staff | | January 26, 2022

Self-Help Aids Quality of Life for People With Psoriasis

Findings show modest, but significant, benefit from either compassion-based or mindfulness-based self-help

By Physician’s Briefing Staff | | January 25, 2022

Risk for Cancer Increased After VTE for Patients With Psoriasis

Standardized incidence ratio was 3.0 during first year of follow-up after VTE and decreased to 1.5 during subsequent years

By Physician’s Briefing Staff | | January 24, 2022

Biosimilars Could Cut Spending for Biologic Therapy in the U.S.

Increased market growth of biosimilars that are similar to brand-name biologic agents has the potential to reduce spending on prescription drugs

By Physician’s Briefing Staff | | January 21, 2022

Recommendations Updated for Recombinant Zoster Vaccine

Recommendations have been updated for use of the recombinant zoster vaccine (RZV) for prevention of herpes zoster and related complications among immunocompromised adults aged...

By Physician’s Briefing Staff | | January 20, 2022

Is Electrical Impedance Spectroscopy Beneficial for Detecting Melanoma?

EIS increases diagnostic confidence for students and dermatologists assessing lesions clinically suspicious for melanoma

By Dermsquared Editorial Team | | January 19, 2022

Does Telemedicine Help to Cut Nonattendance for Dermatology Patients?

Telemedicine linked to substantially reduced nonattendance rates in pediatric patients, but not in patients aged 65 years and older

By Dermsquared Editorial Team | | January 19, 2022

Specialist-Led Model of Care Can Improve CVD Prevention in Psoriasis

Dermatologists and patients with psoriatic disease approve of a specialist-led model of care

By Physician’s Briefing Staff | | January 19, 2022

FDA Approves Rinvoq for Treatment of Atopic Dermatitis

Approval indicated for those 12 years and older with atopic dermatitis that has not responded to previous treatment

By Physician’s Briefing Staff | | January 19, 2022

24 of 1292

Headline from the Week of October 19 - 25, 2026

The Distance Between Habit and Strategy

By Dermsquared Editorial Team | | October 23, 2026

From Poster to Practice: The Control Gap in CIndU

| October 23, 2026